Cholesterol-lowering drugs protect a range of hearts. A landmark trial of cholesterol-lowering statin drugs demonstrates their benefit in women, older people, and maybe even those with "normal" cholesterol levels.
D017677:Age Distribution; D000368:Aged; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D006937:Hypercholesterolemia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012016:Reference Values; D018570:Risk Assessment; D017678:Sex Distribution; D019821:Simvastatin / Q000008:administration & dosage*; D016896:Treatment Outcome; D006113:United Kingdom
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin